key: cord-0891878-58f98g74 authors: Hunter, John G title: Commentary on: Estimated National and Regional Impact of COVID-19 on Elective Case Volume in Aesthetic Plastic Surgery date: 2020-12-14 journal: Aesthet Surg J DOI: 10.1093/asj/sjaa303 sha: 4f46b0cd827bec2ca444949c29cb32f45f4a7695 doc_id: 891878 cord_uid: 58f98g74 nan Writing a commentary is an interesting experience for those invited, at least I have found it to be so. Commentators have both the opportunity and responsibility to highlight the salient points of the article in question and to offer pithy critiques based on their expertise in the subject matter being commented on. As someone invited by the editors and editorial staff (full disclosure: I am a member of the editorial board) of Aesthetic Surgery Journal to do so a number of times on a few topics on which I allegedly have some expertise, I have been honored to contribute over the past decade. I have, however, found this to be by far the most difficult ASJ commentary I have ever written, in part because I am not an expert on SARS-CoV2; I am not sure anyone truly yet is. "Up close and personal" involvement with COVID-19 in my hospital fiduciary roles this past March to June in New York City did not make me a COVID expert. It is called a "novel" Coronavirus for a reason; as best we know, humankind has never experienced, nor have international health care systems ever dealt with, this unique Coronavirus before. Besides, the accepted manuscript iteration of Drs Bregman, Cook, and Thorne 1 was submitted in June of 2020, before the SARS-CoV2 case "surge/second wave" that subsequently occurred in Florida, California, Texas, Arizona, and generally across many southern and southwestern US states. Or the "third wave" that is now occurring across the United States (as we also enter influenza season), with over 99,000 new COVID-19 positive tests reported in the country on October 30, 2020, alone. At least 31 US states recorded their highest SARS-CoV2 positive test results in October. Johns Hopkins Coronavirus Resource Center reported almost 9.2 million total US cases and almost 230 thousand total US deaths (1.199 million globally) that same day. 2 Europe is also now experiencing unprecedented COVID-19 case volumes, and many countries are again considering or already imposing draconian societal shutdowns approaching those of the European first wave. So, writing a meaningful commentary on the authors' paper, Estimating National and Regional Impact of COVID-19 on Elective COVID-19 on Elective Case Volume in Aesthetic Plastic Surgery, is difficult. The authors' paper is well-written, and their analysis based on available data at the time written/submitted is coherent and presented well. 1 I also concur with their conclusion that the "cumulative impact of the pandemic on life, society, and the economy is tremendous." 1 We just cannot and do not yet really know COVID-19's impact, economic and otherwise, on much in medicine, especially aesthetic surgery. Nor will we be able to for a while. Because of the evolving nature of a novel event-the COVID-19 global pandemic-and varied US national and local (state) policy responses to it, evaluating or commenting on the continued validity of the authors' assumptions and predictions is very difficult, especially as we enter the late fall and winter of 2020/2021. The authors utilize models developed by the Institute for Health Metrics and Evaluation (IHME) from March 2020. Unfortunately, IHME models have also been a moving target, which is not the authors' fault, because they are based on ever-changing data sets. IHME projections have changed rather significantly (again, based on assumptions included), and multiple times, over the course of the pandemic. The authors hail from downstate New York State, New York City and Long Island, as I do. Their hospital enterprise, Northwell Healthcare, dealt with the worst of the SARS-CoV2 East Coast first wave as did my hospital enterprise, New York-Presbyterian. Both systems, along with all New York City hospitals, experienced the first large US iteration of COVID-19 in an unprecedented manner none of us ever want to experience again. In addition to the human toll on patients and our staff, New York-Presbyterian enterprise lost over $1 billion due to the pandemic through Q2 2020. Now another surge is upon us. Not to speak for the authors, but I believe I can safely state that none of us want to repeat our experience from March through May, an experience, unfortunately, an iteration of which is now occurring in many other US states. It appears unlikely that there is political will in the United States to widely shut down elective surgery again. National and state politics, SARS-CoV2, as well as the eventual availability of a vaccine and the fact that our remarkable medical colleagues have gotten much better at dealing with this novel virus will decide the ongoing COVID-19 response (mostly the COVID-19 virus itself). But, again, we just do not know. Aesthetic surgery case volumes are up (according to multiple publications) in New York City and elsewhere in New York State since the lifting of Governor Andrew Cuomo's executive order prohibition in March of elective surgery in New York State. Is this just pent up demand? Unfortunately, we do not know. Will it last? With current US economic conditions, uncertainty related to a "novel virus" behavior, and political issues related to response, predicting is not easy or certain. By the time this commentary is published, it too will be outdated, which is the problem with an ongoing pandemic that has already killed 230,000 Americans and 1.2 million individuals worldwide. 2 Although not usually part of an invited commentary, as it is not related to the manuscript itself, I offer the following that may provide some odd comfort during these difficult times: pandemics are common and have occurred throughout recorded time since humans have spread across our planet. During the Antonine Plague (165-180 AD), approximately 5 to 10 million people died (smallpox suspected), and the Plague of Justinian (541-549 AD from Yersinia pestis) killed 30 to 50 million, an estimated 40% to 50% of the population of Europe. 3 The bad news is that pandemics regularly visit us, and if the past 2000 years of human history are accurate, COVID-19 will not be the last one. The good news is that humanity (and aesthetic surgery) will survive SARS-CoV2. Again, Drs Thorne and colleagues are commended for this work, especially for doing it during the most difficult time during the COVID-19 surge in downstate New York, New Jersey, and Connecticut this past spring. In the midst of another COVID surge through the majority of the United States, it is difficult to accurately assess COVID-19's ultimate impact on much in US healthcare. This will be done retrospectively. I also reiterate the authors' statement that the impact of this pandemic has been and will, unfortunately, be calamitous. Stay safe and healthy. Dr Hunter receives book royalties from Thieme Medical Publishers. Estimated national and regional impact of COVID-19 on elective case volume in aesthetic plastic surgery Visualizing the history of pandemics The author received no financial support for the research, authorship, and publication of this article.